Journals / Glokom Katarakt / 2017 / Cilt: 12 - Sayı: 2

Cystic Macular Edema Secondary to Prostaglandin Analog

Prostaglandin Analoğuna Sekonder Kistik Makula Ödemi

Pages
141–144
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Our case was presented here, because CME might be treated in other ways in case of failure to correct evaluation of the clinical picture and its importance for this reason.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cystoid macular edema (CME) can develop due to a variety of causes.
📊
Key Findings & Data:A-82 year-old man with primary open angle glaucoma followed in our glaucoma department developed vision loss 3 months after the addition of a prostaglandin analog agent to his current anti-glaucoma treatment.
💡
Conclusion & Impact:Our case was presented here, because CME might be treated in other ways in case of failure to correct evaluation of the clinical picture and its importance for this reason.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cystoid macular edema (CME) can develop due to a variety of causes. It is also known that some medications can cause CME. Antiglacomatous agents from the group of prostaglandin analogues are among of these medications. A-82 year-old man with primary open angle glaucoma followed in our glaucoma department developed vision loss 3 months after the addition of a prostaglandin analog agent to his current anti-glaucoma treatment. An epiretinal membrane (ERM) and CME was diagnosed after optical coherence tomographic investigation. Although established ERM could be accused for CME, prostaglandin analog was discontinued because of development of visual symptoms 3 months after starting the prostaglandin analog, and his vision started to improve with recovery of CME beginning 1 week after discontinuation. Our case was presented here, because CME might be treated in other ways in case of failure to correct evaluation of the clinical picture and its importance for this reason.

Özet

Kistik makula ödemi (KMÖ) bir çok nedene bağlı gelişebilmektedir. Kullanılan bazı ilaçların da KMÖ'ye neden olabildiği bilinmektedir. Bu ilaçlardan birisi de prostaglandin analogu antiglokomatöz ajanlardır. Glokom birimimizde takip edilen 82 yaşındaki erkek olgu mevcut antiglokomatöz tedavisine ilave edilen prostaglandin analogu kullanımından 3 ay sonra başlayan görme keskinliği azalmasından yakınmış ve yapılan incelemede epiretinal membran ve kistik makula ödemi saptanmıştır. Saptanan KMÖ, eşlik eden ERM'na bağlanabilecek iken olgunun semptomunun prostaglandin analogu başlanmasından 3 ay sonra gelişmesi nedeni ile prostaglandin analogu kesilmiş ve 1. haftadan itibaren hastanın görmesi düzelmeye KMÖ ise kaybolmaya başlamıştır. Olgumuz, doğru değerlendirilememesi durumunda KMÖ'nin başka yollar ile tedavisine yol açabileceği ve bu nedenle önemli olduğu düşüncesi ile burada sunulmuştur.

🔖

Cite This Article

İNAN, S., ÇETİNKAYA, E. (2017). Cystic Macular Edema Secondary to Prostaglandin Analog. Glokom Katarakt, Cilt: 12 - Sayı: 2, 141–144. https://ajindex.com/articles/192606

References (10)

  1. Rotsos TG, Moschos MM. Cystoid macular edema. Clin Ophthal- mol 2008;2:919-30. Koçak N,Kaynak S. Makula Ödeminde Semptomatoloji, Klinik Tanı ve Epidemiyoloji. Turkiye Klinikleri J Ophthalmol-Special Topics 2013;6:12-4 Holló G. The side effects of the prostaglandin analogues. Expert Opin Drug Saf. 2007;6:45-52.
  2. Agange N, Mosaed S. Prostaglandin-Induced CystoidMacu- lar Edema Following Routine Cataract Extraction. J Ophthal- mol. 2010;2010:690707 Miyake K, Ota I, Maekubo K et all. Latanoprost accelerates dis- ruption of the blood-aqueous barrier and the incidence of angiog- raphic cystoid macular edema in early post-operative pseudopha- kias. Arch Ophthalmol. 1999; 117:34-40.
  3. Arcieri ES, Santana A, Rocha FN et all. Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia or aphakia: a 6-month randomized trial. Arch Opht- halmol. 2005;123:186-92.
  4. Furuichi M, Chiba T, Abe K et al. Cystoid macular edema associa- ted with topical latanoprost in glaucomatous eyes with a normally functioning blood-ocular barrier. J Glaucoma. 2001;10:233-6.
  5. Matsuura K, Sasaki S, Uotani R. Successful treatment of prostag- landin-induced cystoid macular edema with subtenon triamcinolo- ne. Clin Ophthalmol. 2012;6:2105-8.
  6. Brasil OF, Brasil MV, Ventura MP et all. Bilateral and simultane- ous cystoid macular edema associated with latanoprost use: re- port oftwo cases. Arq Bras Oftalmol. 2010;73:186-8.
  7. Sacchi M, Villani E, Gilardoni F et all. Effi cacy of intravitreal dexamethasone implant for prostaglandin- induced refractorypseudophakic cystoid macular edema: case report and review of the literature. Clin Ophthalmol. 2014 2;8:1253-7.
  8. Tufan HA, Gencer B. Latanoprost Kullanımına Bağlı Santral Seröz Koriyoretinopati.Ret-Vit 2013;21:139-141. Yalçınbayır Ö. Makula Anatomisi,Histolojisi ve Fizyolojisi Turkiye Klinikleri J Ophthalmol-Special Topics 2013;6 Wand M1, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids Am J Ophthalmol. 2002;133:403-5.
  9. Grigoropoulos VG, Emfi etzoglou I, Nikolaidis P et all. Cystoid macular oedema within 24 h after a single application of latanoprost Int Ophthalmol. 2009;29:257-9. Makri OE1, Georgalas I, Georgakopoulos CD. Drug-induced macular edema. Drugs. 2013;73: 789-802.
  10. Russo A, Costagliola C, Delcassi L, Parmeggiani F et all. Topical Nonsteroidal Anti-Infl ammatory Drugs for Macular Edema. Mediators Infl amm. 2013;2013:476525.